Subspecialties

Are a significant number of users risking retinal damage?

What does analysis of the last five years of literature on branch retinal vein occlusion tell us about the priorities of the field and the major contributors to it?

Regeneron released preliminary data of the DRCR.net Protocol T trial. The DRCR.net hasn‘t, and won’t for a while.

Sitting Down With… John Kanellopoulos Clinical Professor of Ophthalmology, New York University Medical School, Partner at OMMA Eye Institute, and Founder and Scientific Manager of Laservision.gr Institute, Athens, Greece

What does analysis of the last five years of the literature on vitreomacular traction/ adhesion tell us about the priorities of the field and the major contributors to it?

Sitting Down With… Charles McGhee, Director of the New Zealand National Eye Centre, University of Auckland, New Zealand.

Mark Latina recounts his story of the invention of selective laser trabeculoplasty (SLT).

Fusing the embryos of mice, where one contains a marker of its lineage, is a well-established technique in developmental biology research. The stripy corneas were still a surprise, though…

Ophthalmologists would change recommendations if treating themselves

Statins may interfere with glucose metabolism, and their use might be damaging the diabetic eye. Or perhaps not...